Germany
Japan
United Kingdom
China
Peroxidase Conjugated Goat Anti-Rabbit IgG (Min Hu, Ms)
| Applications | WB: 1:3,000-10,000; ELISA: 1:20,000-40,000 |
| Reactivities | Rabbit IgG |
| Conjugation | HRP |
Antibodies
USD 428.00
In Stock
IL20 goat polyclonal antibody, Biotin
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Biotin |
VIII mouse monoclonal antibody, clone B62-FE2, FITC
| Applications | ELISA |
| Conjugation | FITC |
Peroxidase Conjugated Goat Anti-Rabbit IgG (gamma-chain specific)
| Applications | WB: 1:3,000-10,000; ELISA: 1:20,000-40,000 |
| Reactivities | Rabbit IgG |
| Conjugation | HRP |
Goat Anti-Rabbit IgG Secondary Antibody
| Applications | WB, IHC, IF/ICC, ELISA |
| Reactivities | Rabbit IgG |
| Conjugation | Unconjugated |
USD 260.00
5 Days
Human IgG4 (pFC) mouse monoclonal antibody, clone HP6023 (also known as HO6023), HRP, Purified
| Applications | ELISA: 1/4000-1/8000 (See also Ref.2-9). Applications Reported in Literature: Flow Cytometry (Ref.15,18,19). Immunohistochemistry on Frozen Sections (Ref.10). Immunohistochemistry on Paraffin Sections (Ref.5,7,10,11). Immunocytochemistry (Ref.12). Immunoblotting (Ref.3,13-16). Microarray (Ref.17). Multiplex (Ref.2,20-22). Purification (Ref.15). |
| Reactivities | Human |
| Conjugation | HRP |
USD 300.00
5 Days
Human IgG4 (pFC) mouse monoclonal antibody, clone HP6023 (also known as HO6023), AP, Purified
| Applications | ELISA: 1/1000-1/2000 (See also Ref.2-9). FLISA. Applications Reported in Literature: Flow Cytometry (Ref.15,18,19). Immunohistochemistry on Frozen Sections (Ref.10). Immunohistochemistry on Paraffin Sections (Ref.5,7,10,11). Immunocytochemistry (Ref.12). Immunoblotting (Ref.3,13-16). Microarray (Ref.17). Multiplex (Ref.2,20-22). Purification (Ref.15). |
| Reactivities | Human |
| Conjugation | AP |
USD 180.00
In Stock
DDK Rabbit monoclonal antibody,clone OTIR5G2, recognizes both N-terminal and C-terminal DDK tags
| Applications | ELISA, IP, WB |
| Conjugation | Unconjugated |
Special Offer: Get this product for $99/€99. Use code: "Truesample".
USD 260.00
2 Weeks
Parathyroid Hormone (PTH) (53-84) mouse monoclonal antibody, clone D1.5, Purified
| Applications | ELISA, IHC |
| Reactivities | Human |
USD 390.00
In Stock
MHC Class I Heavy Chain (Restricted expression) mouse monoclonal antibody, clone HC10, Purified
| Applications | ELISA, EM, FC, IF, IHC, IP, WB |
| Reactivities | Human |
Biotinylated Anti-Human IL-17E Rabbit Polyclonal Antibody
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
MRP8/14 (S100A8/A9) mouse monoclonal antibody, clone 27E10, Purified
| Applications | ELISA, IHC |
| Reactivities | Human |
Vaccinia Virus (Lister Strain) rabbit polyclonal antibody, Purified
| Applications | ELISA, IHC |
CRP mouse monoclonal antibody, clone PC1, Purified
| Applications | ELISA, WB |
| Reactivities | Porcine |
IGHG4 mouse monoclonal antibody, clone HP6025, AP, Purified
| Applications | ELISA: 1/1000-1/2000 (2-9). Immunohistochemistry on Frozen Sections: reported in literature (5,7,10,11). Immunohistochemistry on Paraffin Sections: reported in literature (10). Flow Cytometry: reported in literature (15, 18, 19). Immunocytochemistry: reported in literature (12). Western Blot: reported in literature (3,13-16). |
| Reactivities | Human |
| Conjugation | AP |
USD 250.00
2 Weeks
Goat Anti-Mouse IgG Secondary Antibody
| Applications | WB, IHC, IF/ICC, ELISA |
| Reactivities | Mouse IgG |
| Conjugation | Unconjugated |
ICAM1 mouse monoclonal antibody, clone MEM-111, Purified
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Bovine, Human, Rat |
Canine Parvovirus mouse monoclonal antibody, clone CPV1-2A1, Purified
| Applications | ELISA, IHC |
| Reactivities | Canine, Feline |
USD 450.00
2 Weeks
Human IgA mouse monoclonal antibody, clone NI 69 (A89-034) and NI 184 (A89-035), Ascites
| Applications | To identify the presence of IgA in Human serum, other body fluids, cell and tissue substrates and to determine its concentration in techniques as Radioimmunoassay, ELISA, Indirect Immunoperoxidase and Immunofluorescence staining of cytoplasmic IgA, Haemagglutination and Immunoblotting. General Recommended Dilutions: Histochemical Use: 1/50-1/200. ELISA: from 1/500 upwards. Western blot: from 1/1000 upwards. |
| Reactivities | Human |
USD 260.00
2 Weeks
gamma Tubulin (TUBG1) (434-449) mouse monoclonal antibody, clone TU-32, Aff - Purified
| Applications | ELISA, IF, WB |
| Reactivities | Mammalian, Plant |
Symetric Dimethylarginine (SDMA) rabbit polyclonal antibody, Serum
| Applications | ELISA, IF, IHC, R, WB |
USD 415.00
2 Weeks
Adeno-Associated Virus 2 / AAV2 (intact particle) mouse monoclonal antibody, clone A20, Purified
| Applications | ELISA, FN, IF, IHC, IP |
| Reactivities | Human, Monkey |
Cystatin C (CST3) rabbit polyclonal antibody, Aff - Purified
| Applications | ELISA, WB |
| Reactivities | Human |
Lipoteichoic Acid (LTA) mouse monoclonal antibody, clone 55, Low Endotoxin
| Applications | ELISA, IF, IHC, WB |
Candida albicans rabbit polyclonal antibody, Purified
| Applications | ELISA, ID, Ie, IF, IHC |
| Reactivities | Candida |
Biotin Conjugated Goat Anti-Rabbit IgG
| Applications | WB: 1:200-400; ICC: 1:100-200; IHC: 1:100-200; ELISA: 1:5,000-20,000 |
| Reactivities | Rabbit IgG |
| Conjugation | Biotin |
USD 745.00
5 Days
ACTH (POMC) (1-24) mouse monoclonal antibody, clone 57 (BGN/1388/66), Aff - Purified
| Applications | ELISA, IHC |
| Reactivities | Human, Rat |
beta 2 Microglobulin (B2M) rabbit polyclonal antibody, HRP
| Applications | ELISA, EM, IHC, WB |
| Reactivities | Human |
| Conjugation | HRP |
pan Dengue Virus mouse monoclonal antibody, clone Dengue 1-11(3), Purified
| Applications | ELISA, IF, IHC, WB |
Rabbit Anti-Mouse IgG Secondary Antibody
| Applications | WB, IHC, IF/ICC, ELISA |
| Reactivities | Mouse IgG |
| Conjugation | Unconjugated |
Collagen II (COL2A1) rabbit polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC, IP, WB |
| Reactivities | Bovine, Human, Mouse, Rat, Sheep |
Testosterone (3-CMO-BSA) mouse monoclonal antibody, clone 7003, Purified
| Applications | ELISA, IF, R |
| Reactivities | Human |
C1QA mouse monoclonal antibody, clone JL-1, Biotin
| Applications | ELISA, FN, IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Biotin |
Active filters
Applications
- ELISA
Filter by
Target Symbol
- S PROTEIN (135)
- IL6 (131)
- UCHL1 (125)
- LCN2 (113)
- GFAP (106)
- IL1RL1 (105)
- N PROTEIN (105)
- IL17A (98)
- S100A8/A9 (87)
- D-DIMER (83)
- MPO (81)
- SAA1 (81)
- FABP3 (71)
- MYBPC3 (63)
- REG1A (62)
- CAPSID (50)
- NEFL (49)
- IGG4 (38)
- H3C1 (37)
- NPPB (37)
- AMH (34)
- EGFR (32)
- POMC (29)
- ALB (28)
- PDCD1 (28)
- C3 (27)
- TNF (27)
- COL1A1 (26)
- EGF (26)
- S (26)
- CD80 (25)
- MAPT (25)
- GAG (24)
- PTH (24)
- EDN1 (23)
- F13A1 (23)
- FSHB (23)
- NPPA (23)
- IL2 (22)
- PON1 (22)
- SARS-COV-2 SPIKE PROTEIN (22)
- CD274 (21)
- IFNG (20)
- S100B (20)
- BRAF (19)
- CALCA (19)
- PDYN (19)
- FOLH1 (18)
- IL10 (18)
- LTF (18)
- RBP4 (18)
- B2M (17)
- CSF2 (17)
- IGF1 (17)
- IL7 (17)
- INS (17)
- KITLG (17)
- PENK (17)
- SARS-COV-2 N PROTEIN (17)
- V5 (17)
- CD44 (16)
- HIS (16)
- MUC1 (16)
- COL4A1 (15)
- CXCL12 (15)
- FN1 (15)
- GCG (15)
- IL12A (15)
- IL3 (15)
- AFP (14)
- CCL2 (14)
- CD5 (14)
- IL4 (14)
- IL9 (14)
- MYC (14)
- TP63 (14)
- CD1C (13)
- CRP (13)
- EFNA2 (13)
- EPHX1 (13)
- HA (13)
- KLK3 (13)
- MSMB (13)
- NME1 (13)
- TLE1 (13)
- ADCYAP1 (12)
- CCL3 (12)
- GAL (12)
- GHRL (12)
- HIST1H3A (12)
- IAPP (12)
- MAPK8 (12)
- PRL (12)
- AGT (11)
- AKT1 (11)
- CHGA (11)
- DDK (11)
- GAPDH (11)
- IL1B (11)
- KLK8 (11)
Reactivities
- Human (5446)
- Mouse (1718)
- Rat (1520)
- SARS-CoV-2 (271)
- Mammalian (127)
- Porcine (99)
- Murine (82)
- Monkey (79)
- Bovine (58)
- Dog (49)
- HIV (49)
- Rabbit (25)
- Virus (24)
- Canine (19)
- Pig (12)
- Chicken (11)
- Primate (11)
- C-term DDK (10)
- Feline (9)
- Guinea Pig (9)
- Vertebrates (9)
- Cow (8)
- Goat (8)
- SARS-CoV (8)
- Sheep (8)
- Broad (5)
- Chimpanzee (5)
- Escherichia coli (3)
- Hamster (3)
- Respiratory Syncytial Virus (3)
- Zebrafish (3)
- Avian (2)
- Bacteria (2)
- Cynomolgus (2)
- Dengue virus (2)
- Ferret (2)
- Horse (2)
- Insect (2)
- N-term and C-term DDK (2)
- West Nile Virus (2)
- Yeast (2)
- Yellow Fever Virus (2)
- 5-FAM (1)
- Bacillus Antracis (1)
- Biotin (1)
- C. elegans (1)
- Digoxin (1)
- FITC (1)
- Fish (1)
- Fusion proteins containing the Flag Tag (1)
- Horseradish Peroxidase (1)
- Staphylococcus aureus (1)
- Xenopus (1)
Antibody Hosts
Isotypes
- IgG1 (5108)
- IgG (4822)
- IgG2a (1139)
- IgG2b (909)
- IgG, kappa (166)
- IgG1, kappa (124)
- IgM (113)
- IgG3 (90)
- IgG2a, kappa (35)
- Ig (34)
- IgG2 (24)
- Fab fragment, kappa (19)
- IgG2b, kappa (15)
- IgG1, lambda (11)
- IgY (10)
- IgG1-Fc Fusion (8)
- IgG2c (6)
- IgG3, kappa (5)
- IgG4 (5)
- IgM, kappa (5)
- IgA-Fc Fusion (4)
- IgG-Fc Fusion (4)
- IgM-Fc Fusion (4)
- IgA (3)
- IgE (3)
- cocktail (3)
- IgG2, kappa (2)
- IgG2a, lambda (2)
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (47)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (6)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- Phospho-specific (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Assay Types
Assay Platforms
Families
- Druggable Genome (3786)
- Secreted Protein (1557)
- Transmembrane (1184)
- ES Cell Differentiation/IPS (592)
- Transcription Factors (531)
- Protease (363)
- Protein Kinase (310)
- Stem cell - Pluripotency (200)
- Adult stem cells (121)
- Embryonic stem cells (95)
- Cancer stem cells (72)
- Induced pluripotent stem cells (67)
- Stem cell relevant signaling - JAK/STAT signaling pathway (62)
- GPCR (54)
- Stem cell relevant signaling - DSL/Notch pathway (37)
- Phosphatase (36)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (32)
- Stem cell relevant signaling - Wnt Signaling pathway (23)
- Ion Channels: Other (19)
- Nuclear Hormone Receptor (19)
- P450 (14)
- Ion Channels: Cys-loop Receptors (6)
- Ion Channels: Glutamate Receptors (4)
- Ion Channels: Potassium (4)
- Ion Channels: Transient receptor potential (4)
- Ion Channels: Cyclic nucleotide gated (1)
- Ion Channels: Sodium (1)
Pathways
- Cytokine-cytokine receptor interaction (726)
- Pathways in cancer (579)
- Jak-STAT signaling pathway (370)
- Metabolic pathways (353)
- MAPK signaling pathway (314)
- Focal adhesion (299)
- Hematopoietic cell lineage (282)
- Toll-like receptor signaling pathway (280)
- Hypertrophic cardiomyopathy (HCM) (233)
- Chemokine signaling pathway (231)
- Prostate cancer (219)
- Regulation of actin cytoskeleton (219)
- NOD-like receptor signaling pathway (211)
- ErbB signaling pathway (185)
- Graft-versus-host disease (180)
- T cell receptor signaling pathway (180)
- Melanoma (175)
- Prion diseases (173)
- Systemic lupus erythematosus (165)
- Colorectal cancer (160)
- Pancreatic cancer (159)
- Endometrial cancer (158)
- Glioma (156)
- Bladder cancer (152)
- Cytosolic DNA-sensing pathway (149)
- Parkinson's disease (144)
- Neurotrophin signaling pathway (143)
- Complement and coagulation cascades (138)
- Non-small cell lung cancer (138)
- Natural killer cell mediated cytotoxicity (134)
- Chronic myeloid leukemia (133)
- GnRH signaling pathway (130)
- Cell adhesion molecules (CAMs) (128)
- Gap junction (125)
- Insulin signaling pathway (124)
- TGF-beta signaling pathway (124)
- Acute myeloid leukemia (120)
- Progesterone-mediated oocyte maturation (119)
- Endocytosis (117)
- Fc epsilon RI signaling pathway (117)
- Neuroactive ligand-receptor interaction (117)
- PPAR signaling pathway (116)
- Dilated cardiomyopathy (114)
- Alzheimer's disease (109)
- Cell cycle (106)
- Renal cell carcinoma (106)
- Amyotrophic lateral sclerosis (ALS) (105)
- ECM-receptor interaction (103)
- Apoptosis (99)
- Wnt signaling pathway (96)
- Small cell lung cancer (91)
- Type I diabetes mellitus (89)
- Melanogenesis (87)
- Adipocytokine signaling pathway (86)
- Adherens junction (84)
- Allograft rejection (84)
- B cell receptor signaling pathway (82)
- Epithelial cell signaling in Helicobacter pylori infection (80)
- Fc gamma R-mediated phagocytosis (76)
- RIG-I-like receptor signaling pathway (76)
- Thyroid cancer (76)
- mTOR signaling pathway (74)
- Axon guidance (73)
- Long-term depression (73)
- Vascular smooth muscle contraction (73)
- Leukocyte transendothelial migration (70)
- Oocyte meiosis (70)
- Autoimmune thyroid disease (68)
- Tight junction (66)
- Type II diabetes mellitus (65)
- Calcium signaling pathway (64)
- Long-term potentiation (64)
- p53 signaling pathway (64)
- VEGF signaling pathway (62)
- Glycolysis / Gluconeogenesis (59)
- Huntington's disease (54)
- Dorso-ventral axis formation (51)
- Pathogenic Escherichia coli infection (49)
- Viral myocarditis (49)
- Antigen processing and presentation (45)
- Purine metabolism (45)
- Asthma (42)
- Arginine and proline metabolism (40)
- Cysteine and methionine metabolism (39)
- Notch signaling pathway (39)
- Glutathione metabolism (38)
- Ubiquitin mediated proteolysis (38)
- Metabolism of xenobiotics by cytochrome P450 (37)
- Pyruvate metabolism (37)
- Basal cell carcinoma (29)
- Proteasome (29)
- Regulation of autophagy (29)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (26)
- Pyrimidine metabolism (26)
- Citrate cycle (TCA cycle) (24)
- Maturity onset diabetes of the young (24)
- Tryptophan metabolism (24)
- Lysosome (23)
- Arachidonic acid metabolism (22)
- Cardiac muscle contraction (21)
- Hedgehog signaling pathway (21)
- Nitrogen metabolism (21)
- Drug metabolism - cytochrome P450 (19)
- Butanoate metabolism (18)
- Glycine (18)
- Propanoate metabolism (18)
- Valine (18)
- leucine and isoleucine degradation (18)
- serine and threonine metabolism (18)
- Base excision repair (17)
- Fatty acid metabolism (17)
- Tyrosine metabolism (17)
- One carbon pool by folate (16)
- RNA degradation (16)
- Fructose and mannose metabolism (15)
- Lysine degradation (15)
- Spliceosome (15)
- Vibrio cholerae infection (15)
- beta-Alanine metabolism (15)
- Alanine (14)
- aspartate and glutamate metabolism (14)
- Histidine metabolism (13)
- Nucleotide excision repair (13)
- Pentose phosphate pathway (13)
- Biosynthesis of unsaturated fatty acids (12)
- Oxidative phosphorylation (12)
- Primary immunodeficiency (12)
- Renin-angiotensin system (12)
- Sphingolipid metabolism (12)
- Nicotinate and nicotinamide metabolism (11)
- Phenylalanine metabolism (11)
- ABC transporters (10)
- Amino sugar and nucleotide sugar metabolism (10)
- Mismatch repair (10)
- Folate biosynthesis (9)
- Homologous recombination (9)
- Non-homologous end-joining (9)
- Olfactory transduction (9)
- Phosphatidylinositol signaling system (9)
- Porphyrin and chlorophyll metabolism (9)
- Riboflavin metabolism (9)
- Starch and sucrose metabolism (9)
- Glycerolipid metabolism (8)
- Glyoxylate and dicarboxylate metabolism (8)
- Methane metabolism (8)
- Retinol metabolism (8)
- Ribosome (8)
- SNARE interactions in vesicular transport (8)
- Selenoamino acid metabolism (8)
- Cyanoamino acid metabolism (7)
- Drug metabolism - other enzymes (7)
- Linoleic acid metabolism (7)
- N-Glycan biosynthesis (7)
- Terpenoid backbone biosynthesis (7)
- Aminoacyl-tRNA biosynthesis (6)
- DNA replication (6)
- Glycerophospholipid metabolism (6)
- Primary bile acid biosynthesis (6)
- Taurine and hypotaurine metabolism (6)
- Ether lipid metabolism (5)
- Galactose metabolism (5)
- Synthesis and degradation of ketone bodies (5)
- Caffeine metabolism (4)
- Inositol phosphate metabolism (4)
- Limonene and pinene degradation (4)
- Androgen and estrogen metabolism (3)
- RNA polymerase (3)
- Taste transduction (3)
- Vitamin B6 metabolism (3)
- Ascorbate and aldarate metabolism (2)
- C21-Steroid hormone metabolism (2)
- Circadian rhythm - mammal (2)
- Fatty acid elongation in mitochondria (2)
- O-Glycan biosynthesis (2)
- Pantothenate and CoA biosynthesis (2)
- Pentose and glucuronate interconversions (2)
- alpha-Linolenic acid metabolism (2)
- leucine and isoleucine biosynthesis (2)
- D-Glutamine and D-glutamate metabolism (1)
- Fatty acid biosynthesis (1)
- Lysine biosynthesis (1)
- Other glycan degradation (1)
- Phenylalanine (1)
- Ubiquinone and other terpenoid-quinone biosynthesis (1)
- tyrosine and tryptophan biosynthesis (1)